The research team, led by Hongxia Liu and Yan Wang of the Department of Pediatrics at Henan Provincial People’s Hospital, affiliated with People’s Hospital of Zhengzhou University, set out to address a persistent gap in the literature. Socioeconomic shifts in China have clearly driven an increase in metabolic disorders, but long-term trend data specifically covering youth aged 5 to 24 have remained scarce. Most existing studies focus either on adults or on very young children, leaving adolescents and young adults in a statistical blind spot even though habits formed in these years often persist for life. By analyzing the full 1990 to 2021 period, the researchers could capture the entire arc of China’s extraordinary development, from the early years of market reform through urbanization, dietary change, and the digital era.

At the heart of the study is a metric called the disability-adjusted life year, or DALY, which combines years of life lost to premature death with years lived in disability or ill health. One DALY represents one lost healthy year. By calculating age-standardized DALY rates, abbreviated ASDR, the investigators could compare disease burden across years and populations while accounting for shifts in the age structure of the population. The team focused on four conditions: hypertension, non-alcoholic fatty liver disease, obesity, and type 2 diabetes mellitus. Each of these was once considered an affliction of middle age, yet all four now appear, with varying frequency, among people in their teens and twenties.

The analytical toolkit was considerable. To detect changes in trajectory rather than assuming smooth linear trends, the researchers used Joinpoint regression, a statistical technique originally developed for cancer surveillance that identifies the years at which a trend’s direction or steepness shifts significantly. From these turning points they calculated average annual percentage changes, or AAPCs, which quantify how fast the burden rose or fell. To look forward, they applied a Bayesian age-period cohort model, a probabilistic framework that disentangles the effects of age, calendar time, and birth cohort on disease rates and uses that structure to generate forecasts. Finally, a decomposition analysis partitioned the observed changes in DALYs into three contributing forces: changes in disease rates themselves, population growth, and population aging.

The results tell a story of divergence. Hypertension showed the most encouraging trajectory, with its age-standardized DALY rate falling at an average annual rate of 2.89 percent, a decline that outpaced the global average for the same age group. This improvement, the authors suggest, reflects decades of public health investment, including national salt-reduction awareness efforts and the screening programs embedded in school health services. Yet even this success is incomplete, because hypertension in youth often goes undetected and untreated, silently seeding cardiovascular risk for later life.

Obesity and type 2 diabetes moved in the opposite direction. The age-standardized DALY rate for obesity climbed at an average annual rate of 3.06 percent, while the rate for type 2 diabetes rose at 3.12 percent, both consistent with the upward trends observed globally. These figures align with a broader body of evidence documenting the rapid rise of childhood overweight and obesity in China, driven by increased consumption of sugar-sweetened beverages, ultra-processed foods, and energy-dense diets, alongside a documented decline in physical activity and a surge in sedentary screen time among children and adolescents. The link between early obesity and early-onset type 2 diabetes is well established: excess adiposity in childhood promotes insulin resistance, and the pancreatic beta cells, stressed for years, begin to fail decades earlier than in previous generations. A condition that was once almost unheard of in teenagers is now a recognized pediatric diagnosis in China, prompting the Chinese Medical Association to issue dedicated consensus guidance on managing type 2 diabetes in children and adolescents.

Non-alcoholic fatty liver disease, a condition in which fat accumulates in the liver of someone who drinks little or no alcohol, presented the most nuanced pattern. Across the full 32-year window, its DALY rate declined at an average annual rate of 1.84 percent. But the Joinpoint analysis revealed that this decline was not uniform: after the mid-2010s, the burden rebounded, and the resurgence was particularly pronounced among females. This reversal matters because hepatic steatosis in childhood is increasingly recognized as a marker of broader metabolic risk, and fatty liver disease in the presence of insulin resistance can progress toward inflammation, fibrosis, and, in the long term, cirrhosis and liver cancer. The authors emphasize that this recent resurgence among young women demands targeted attention, and they note that awareness of the condition remains low even among young adults, a gap that randomized intervention trials in China have attempted to close through education campaigns aimed at prevention.

Sex differences emerged as a consistent theme throughout the analysis. Males bore a higher proportion of DALYs across the metabolic conditions studied, a pattern that echoes physiological and behavioral research on why men accumulate more abdominal visceral fat, the metabolically active depot most strongly linked to insulin resistance and cardiovascular risk. Behavioral factors compound the biology: smoking initiation in adolescence remains common among Chinese males, and smoking interacts with metabolic disease in ways that accelerate vascular damage. At the same time, the female-specific rebound in fatty liver disease highlights that risk is not distributed simply, and the authors argue explicitly for sex-specific public health strategies rather than one-size-fits-all interventions.

The decomposition analysis added a crucial interpretive layer. It showed that the increases in DALYs were driven primarily by epidemiological change, meaning shifts in the underlying rates of disease themselves, rather than by demographic forces. Population growth and population aging actually exerted mitigating effects on the age-standardized burden, underscoring that the worsening picture is not an artifact of there simply being more young people. The diseases themselves are becoming more common relative to population size, which makes the trend harder to dismiss and more consequential for health planning.

Looking ahead, the Bayesian projections to 2030 extend the bifurcation into the coming decade. Hypertension is forecast to continue improving, but obesity and type 2 diabetes are predicted to worsen, placing an expanding burden on young people precisely at the ages when they enter the workforce and begin families. The findings arrive as China pursues national frameworks including the Outline for Building a Healthy China 2030, the National Nutrition Plan, and dedicated policies on weight control among children and adolescents and on strengthening school physical education. The study’s message to policymakers is that these frameworks must be sharpened and targeted: the hypertension gains show that sustained intervention works, while the relentless rise of obesity and diabetes shows where the next battle lies. Without urgent, sex-aware, and age-tailored action, a generation of young Chinese faces a future in which the chronic diseases of adulthood arrive decades early.

Subject of Research: Long-term trends in the burden of hypertension, obesity, type 2 diabetes, and fatty liver disease among Chinese youth aged 5 to 24 from 1990 to 2021

Article Title: The burden of metabolic diseases in Chinese youth, 1990–2021: a Global Burden of Disease Study 2021

Article References: Liu, H., Zhang, B., Ma, C., Sun, X., Gao, L., & Wang, Y. (2026). The burden of metabolic diseases in Chinese youth, 1990–2021: a Global Burden of Disease Study 2021. Pediatric Research. https://doi.org/10.1038/s41390-026-05311-x

Image Credits: AI Generated

DOI: 10.1038/s41390-026-05311-x

Keywords: Global Burden of Disease, Chinese youth, obesity, type 2 diabetes, hypertension, non-alcoholic fatty liver disease, DALY, pediatric metabolic health, sex disparities, Bayesian projection, public health, epidemiology

The study’s central innovation is methodological. Rather than relying on mortality rates alone, which can be misleading when disease prevalence differs sharply between countries and sexes, the team calculated the mortality-to-prevalence ratio, or MPR, dividing the age-standardised mortality rate by the age-standardised prevalence rate. Because ischaemic heart disease is a chronic condition, the population at risk of dying includes both newly diagnosed patients and the millions living with established disease, making prevalence a more appropriate denominator than incidence. A high MPR signals that, relative to the number of people living with the disease, deaths are excessive, a pattern that often points to weaknesses in prevention, treatment or both. The researchers also normalised risk-attributable mortality by prevalence to construct a case-fatality index, or CFI, which asks whether deaths attributable to a specific risk factor, such as tobacco or high blood pressure, are high or low among those actually living with the disease.

The headline numbers show genuine progress. Between 2011 and 2023, age-standardised mortality from ischaemic heart disease fell across the region in both sexes, with relative reductions of 2.6 percent in men and 3.7 percent in women, and regional mean MPRs declined from 5.32 percent to 4.32 percent in men and from 5.84 percent to 4.48 percent in women. Yet the averages conceal extraordinary heterogeneity. In 2023, mortality rates among men ranged from 216.93 per 100,000 in Hungary and 210.50 in Bulgaria down to just 63.55 in Slovenia, with women showing a parallel spread from 158.62 in Serbia to 29.17 in Slovenia. Slovenia’s case-fatality levels were statistically indistinguishable from those of the six founding members of the European Union, demonstrating that Western European outcomes are achievable within the region.

When the researchers applied formal Z-score testing to sex differences in MPR, a clear geography of inequality emerged. In 2011, women had significantly worse outcomes in Croatia, Serbia, Czechia and Bosnia and Herzegovina, while men fared worse in Poland and Bulgaria. By 2023, the disparities had narrowed but persisted in Croatia, Serbia and Czechia, with Z-scores of 5.55, 2.55 and 2.18 respectively, while Poland showed a significant reversal, with men now experiencing the higher mortality burden relative to prevalence. In Croatia and Serbia, women’s case-fatality was 46 percent and 38 percent higher than men’s, respectively. More modest but still meaningful female disadvantages appeared in Slovakia, Montenegro, North Macedonia and Bosnia and Herzegovina, whereas Bulgaria and Poland were the only countries where women-to-men ratios fell below one.

What drives these divergent patterns? The analysis points to two opposing domains of risk. In most countries, women exhibited higher case-fatality indices than men for the major metabolic risks, including elevated systolic blood pressure, fasting plasma glucose, LDL cholesterol and body mass index, with Croatia, Serbia and Slovakia showing the most pronounced female disadvantage, exceeding 20 percent for all four. Physical inactivity exerted a proportionally far greater impact on women, particularly in the Balkans, where the female-to-male CFI ratio reached 4.57 in Croatia and 4.11 in Serbia. Tobacco, by contrast, remained an overwhelmingly male hazard, with Albania’s tobacco-attributable male burden nearly six times that of women. In countries such as Croatia and Serbia, the female disadvantage domain of inactivity, metabolic vulnerability and dietary deficits predominates, while in Poland the absence of a strong female disadvantage leaves the universal male hazard from tobacco unopposed, helping to explain the reversal of the sex gap there.

Diet emerged as a critical and underappreciated component of the female disadvantage. Because dietary estimates carry wide uncertainty intervals, the team used Slovenia, the country with the lowest case-fatality, as an empirical benchmark, a choice validated by the finding that Slovenia’s MPR is statistically comparable to those of Belgium, France, Germany, Italy, Luxembourg and the Netherlands. This benchmarking revealed significant sex differences for seven dietary risks: low intake of whole grains, fruits, nuts and seeds, vegetables, seafood omega-3 fatty acids and fibre, along with high sodium intake. Low intake of nuts and seeds was the only dietary factor consistently associated with a significant female disadvantage in all three high-disparity countries, Croatia, Serbia and Czechia, suggesting a shared and potentially tractable population-level pattern. Country-specific deficits added further risk, most notably low fruit and vegetable intake in Croatia and low omega-3 intake in Romania, while male-specific dietary excesses were confined to isolated exposures such as high sodium in Romania and low whole grains in Bulgaria.

The biological plausibility of these dietary effects is well supported. Low intake of fruit, vegetables, nuts, seeds and omega-3-rich foods has been linked to higher blood pressure, impaired vascular function, inflammation and adverse cardiometabolic profiles, and these foods are foundational to the Mediterranean, DASH and Nordic dietary patterns with strong outcome evidence. The authors also point to possible physiological amplification in women, noting that the menopausal transition, with declining oestrogen levels, is associated with adverse lipid changes and vascular dysfunction that may heighten the impact of inadequate intake of omega-3-rich foods and micronutrient-dense sources such as nuts and seeds. Weight-promoting medications, including certain antidepressants, beta-blockers and insulin, may further compound cardiometabolic risk in midlife and older women, although medication use was not directly assessed in this ecological analysis.

Socioeconomic forces appear to compound these physiological vulnerabilities in a structural paradox: women with heart disease may experience relative deprivation of protective foods despite potentially greater nutritional needs. Croatia, though a high-income country, maintains one of the highest at-risk-of-poverty rates in the European Union at 21.7 percent, while upper-middle-income Serbia shows similarly high social vulnerability at 24.3 percent. Food insecurity, unequal household food allocation, gendered norms influencing food selection and time poverty from unequal domestic and caregiving responsibilities may all restrict women’s consistent access to nutrient-dense foods. Czechia offers a contrasting case, where excess female risk emerges despite low poverty levels of roughly 9.5 percent, suggesting that even a comparatively modest additional female shortfall in nuts and seeds, within a population-wide deficit of whole grains and fibre, may be sufficient to produce measurable sex differences in case-fatality.

Health-system capacity alone does not explain the patterns either. The researchers examined coronary revascularisation rates relative to disease prevalence and found that a country’s procedural capacity does not predict its pattern of sex disparity. Croatia and Bulgaria had among the highest procedure-to-prevalence ratios in the region, yet Croatia exhibited a significant disparity disadvantaging women while Bulgaria showed near-identical case-fatality between the sexes. This indicates that equitable outcomes depend not only on system capacity but on the fairness of clinical pathways determining who receives treatment. The findings align with individual-level data: Poland’s male disadvantage corresponds with registry evidence of higher sudden out-of-hospital cardiac arrest in men, while Serbia’s female disadvantage is consistent with Belgrade coronary care data showing higher in-hospital mortality in women with ST-elevation myocardial infarction even after adjustment for age and comorbidities.

The authors are careful to note the limitations of their approach. The analysis relies on modelled GBD estimates rather than primary clinical datasets, its ecological design precludes causal inference at the individual level, and the mortality and prevalence inputs of the MPR are structurally interrelated within the GBD modelling framework, meaning the ratio should be interpreted as a comparative indicator rather than a direct survival estimate. Nevertheless, the message for policymakers is clear: declining mortality does not automatically translate into equitable survival. The researchers call for cardiovascular surveillance systems to complement traditional mortality statistics with sex-specific, prevalence-adjusted indicators, and for a dual-track prevention strategy that confronts the pervasive male tobacco epidemic while addressing the female triad of physical inactivity, poor diet and metabolic risk. Slovenia demonstrates that low case-fatality is achievable in the region; the task now is to translate that benchmark into targeted, sex-sensitive action in the countries where preventable risks continue to drive excess deaths.

Subject of Research: Sex differences in ischaemic heart disease case-fatality and their dietary and lifestyle determinants across Central Europe

Article Title: Contributions of diet and lifestyle to sex differences in ischaemic heart disease burden in Central Europe: an analysis of the Global Burden of Disease Study 2023

Article References: Bugiardini, R., Rahaman, T., Badimon, L., Cenko, E., Anand, S. S., Manfrini, O., Merkely, B., Milicic, D., Townsend, N., Vaccarino, V., Gulati, M., & Gale, C. P. (2026). Contributions of diet and lifestyle to sex differences in ischaemic heart disease burden in Central Europe: an analysis of the Global Burden of Disease Study 2023. The Lancet Regional Health – Europe, 70, Article 101846. https://doi.org/10.1016/j.lanepe.2026.101846

Image Credits: AI Generated

DOI: 10.1016/j.lanepe.2026.101846

Keywords: ischaemic heart disease, Global Burden of Disease, Central Europe, sex disparities, case-fatality, dietary risk factors, physical inactivity, tobacco, hypertension, mortality-to-prevalence ratio, cardiovascular prevention, nutrition policy

The research team, led by Areesh Mevawalla and Timothy M. Pawlik of The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, drew on the 2022 Behavioral Risk Factor Surveillance System, an annual, state-based telephone survey administered by the Centers for Disease Control and Prevention. Because the Caregiver Module was administered in Georgia, Louisiana, Mississippi, New Hampshire, Ohio, Oregon, Pennsylvania, Utah, Virginia, Washington, Wisconsin, and Puerto Rico, the analysis was restricted to those jurisdictions, with CDC-provided sampling weights, strata, and primary sampling units used to generate population-representative estimates. Of the 10,923 caregivers in the analytic cohort, 1,483, or 13.6 percent, were caring for someone whose main health problem was cancer.

The outcome of interest was frequent mental distress, defined using established BRFSS methodology as fourteen or more days in the past thirty during which stress, depression, or emotional problems made mental health not good. The investigators focused on four modifiable protective factors, each selected a priori for its established relevance to psychological distress: sufficient sleep, defined as at least seven hours per night; regular physical activity outside of job duties in the past thirty days; non-smoking status; and adequate emotional support, meaning support was usually or always available. By summing these binary indicators, the team constructed a Cumulative Protective Factor Score ranging from zero to four, allowing them to test a central theoretical premise drawn from the Stress-Buffering Hypothesis, the idea that layered psychosocial and behavioral resources can blunt the corrosive mental health effects of sustained stress.

The demographic portrait of cancer caregivers differed in subtle but meaningful ways from their non-cancer counterparts. Cancer caregivers were slightly older, with a median age of fifty-nine years, and more likely to be female, at 64.3 percent versus 61.4 percent. Their caregiving was typically shorter in duration, with cancer caregivers more likely to have been providing care for one to six months or six months to under two years, whereas non-cancer caregivers more commonly reported commitments of five years or longer, reflecting the episodic but intensive nature of cancer treatment trajectories. Cancer caregivers were also more likely to be caring for a spouse or partner or a non-relative friend, while non-cancer caregivers more frequently cared for children or grandchildren.

Across every protective factor measured, cancer caregivers fared worse. They were less likely to report sufficient sleep, at 60.1 percent versus 64.5 percent; regular physical activity, at 75.8 percent versus 79.5 percent; non-smoking status, at 84.6 percent versus 89.4 percent; and adequate emotional support, at 71.9 percent versus 78.8 percent, with all differences statistically significant. Only 40.3 percent of cancer caregivers reported all four protective factors, compared with 42.2 percent of non-cancer caregivers. This pattern of depleted reserves coincided with the elevated distress: cancer caregiver status was independently associated with higher odds of frequent mental distress in survey-weighted multivariable logistic regression, with an odds ratio of 2.18.

Each individual protective factor was associated with lower odds of frequent mental distress in the full cohort. Sufficient sleep was linked to roughly a 53 percent reduction in odds, regular physical activity to a 29 percent reduction, adequate emotional support to a 65 percent reduction, and non-smoking status to a 37 percent reduction, all highly significant. However, interaction analyses revealed an important nuance: the protective associations of sleep, physical activity, and emotional support were significantly attenuated among cancer caregivers, with interaction odds ratios ranging from 0.69 to 0.76. In other words, the same behaviors appear to confer somewhat less protection in the context of cancer caregiving, perhaps because the intensity of the caregiving stressor overwhelms single resources acting alone.

The cumulative picture was far more encouraging. Using marginal standardization to estimate fully adjusted predicted probabilities, the researchers found a graded, inverse relationship between the protective factor score and frequent mental distress in both groups. Among caregivers with no protective factors, the predicted probability of distress reached 0.76 for cancer caregivers versus 0.59 for non-cancer caregivers, a substantial and statistically significant gap. That gap narrowed steadily across scores of one, two, and three. At the maximum score of four, predicted distress fell to just 10 percent among cancer caregivers and 7 percent among non-cancer caregivers, a difference that was no longer statistically significant. The co-occurrence of all four health-promoting behaviors and support resources appeared sufficient to offset the heightened psychological burden of cancer caregiving almost entirely.

The findings also exposed a persistent sex disparity that no amount of protective accumulation fully resolved. Female cancer caregivers had 40 percent higher odds of frequent mental distress than males, and predicted probabilities were higher for women at every level of the cumulative score. With no protective factors, the predicted probability of distress was 0.85 for women versus 0.68 for men; even at the maximum score of four, women faced a predicted probability of 0.17 compared with 0.08 for men, both differences highly significant. The authors point to a substantial literature suggesting that women disproportionately assume primary caregiving roles, provide more intensive and complex care, and carry additional cognitive-emotional labor, including coordinating treatment, managing family stress, and supplying emotional support to others. Prior research has found that women caring for an ill spouse were nearly six times more likely to experience depressive or anxious symptoms than non-caregiving women, while the authors caution that lower observed distress among men may reflect under-recognition and reluctance to seek support rather than genuine resilience.

The study has limitations worth noting. Its cross-sectional design precludes causal inference, leaving open the question of whether depleted health behaviors precede distress or follow from it, and all measures were self-reported, introducing potential recall and reporting bias. BRFSS also does not capture primary caregiver status, task complexity, cancer stage, or treatment phase, so some differences in distress may reflect variation in illness course. Even so, the surveillance system remains a well-validated, nationally representative instrument for population-level behavioral research, and the consistency of the graded dose-response pattern strengthens the plausibility of the cumulative buffering effect.

The implications reach well beyond individual self-care advice. The authors argue that cancer centers should routinely screen for caregiver distress as part of patient management, and they point to legislative momentum from the RAISE Family Caregivers Act and the CARE Act, which mandate expanding support services and formally assessing caregiver needs within hospital care. Evidence-backed measures such as subsidized respite care, affordable counseling, and caregiver-inclusive clinic visits have been shown to reduce burden, particularly among high-risk groups. Because women remain at elevated risk even under the most favorable behavioral profiles, and because men’s needs may go unrecognized, the researchers call for sex-responsive, caregiver-centered support models rather than one-size-fits-all programs. As the population of U.S. informal caregivers has grown from roughly 43.5 million in 2015 to nearly 53 million in 2020, the study suggests that a coordinated, multilevel response, spanning sleep promotion, physical activity, smoking cessation, emotional support, and structural policy reform, is essential to protect the mental health of those who sustain cancer care at home.

Subject of Research: Health behaviors, mental distress, and sex disparities among U.S. cancer caregivers

Article Title: Buffering the burden: health behaviors, mental distress, and sex disparities in U.S. cancer caregivers

Article References: Mevawalla, A., Sarfraz, A., Alizai, Q., Angez, M., Bega, R., Chaudhry, M. Q., Ashraf, A., Elemosho, A., Chatzipanagiotou, O. P., & Pawlik, T. M. (2026). Buffering the burden: health behaviors, mental distress, and sex disparities in U.S. cancer caregivers. Journal of Cancer Survivorship. https://doi.org/10.1007/s11764-026-02120-3

Image Credits: AI Generated

DOI: 10.1007/s11764-026-02120-3

Keywords: cancer caregivers, frequent mental distress, health behaviors, BRFSS, sleep, physical activity, emotional support, smoking, sex disparities, caregiver burden, stress-buffering hypothesis, cancer survivorship